Biopolis
Biopolis is a purpose-built biomedical R&D hub at one-north. It houses key public research institutes and private research organizations.
Biopolis Phase 1 is developed by JTC Corporation (JTC) at a cost of S$500 million. Phase 1 of the Biopolis comprises a cluster of seven buildings with a built-up area of 185,000 sqm (2 million sq ft). Phase 1 is home to more than 2,000 scientists, researchers, technicians and administrators. The research community is fully supported by state-of-the-art infrastructure and services catering to the full spectrum of biomedical R&D activities.
Phase 2 of the Biopolis comprised two research buildings, with a built-up area of 37,000 sqm (400,000 sq ft).
Phase 3 of Biopolis broke ground in April 2008. This multi-tenanted research facility is intended to extend basic research activities into translational and clinical research as well as medical technology research.
Read more about this topic: One-North